Global Point-of-Care Testing (POCT) Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
According to APO Research, The global Point-of-Care Testing (POCT) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
This report presents an overview of global market for Point-of-Care Testing (POCT), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Point-of-Care Testing (POCT), also provides the sales of main regions and countries. Of the upcoming market potential for Point-of-Care Testing (POCT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Point-of-Care Testing (POCT) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Point-of-Care Testing (POCT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Point-of-Care Testing (POCT) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc.
Point-of-Care Testing (POCT) segment by Company
1. To analyze and research the global Point-of-Care Testing (POCT) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Point-of-Care Testing (POCT) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Point-of-Care Testing (POCT) significant trends, drivers, influence factors in global and regions.
6. To analyze Point-of-Care Testing (POCT) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Point-of-Care Testing (POCT) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Point-of-Care Testing (POCT) industry.
Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Point-of-Care Testing (POCT) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
According to APO Research, The global Point-of-Care Testing (POCT) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
This report presents an overview of global market for Point-of-Care Testing (POCT), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Point-of-Care Testing (POCT), also provides the sales of main regions and countries. Of the upcoming market potential for Point-of-Care Testing (POCT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Point-of-Care Testing (POCT) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Point-of-Care Testing (POCT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Point-of-Care Testing (POCT) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc.
Point-of-Care Testing (POCT) segment by Company
- Roche
- Abbott
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Ascensia
- Bio-Rad Laboratories
- BioMerieux
- ARKRAY
- Nova Biomedical
- Trividia Health
- Quidel
- Accriva
- OraSure Technologies
- Helena Laboratories
- A. Menarini Diagnostics
- Abaxis (Zoetis)
- Ortho Clinical Diagnostics
- Phamatech
- Chembio Diagnostics
- Trinity Biotech
- ELITech Group
- Response Biomedical
- Princeton BioMeditech
- Alfa Wassermann
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas/Electrolytes Testing
- Urinalysis Testing
- Clinics
- Hospitals
- Laboratory
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Point-of-Care Testing (POCT) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Point-of-Care Testing (POCT) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Point-of-Care Testing (POCT) significant trends, drivers, influence factors in global and regions.
6. To analyze Point-of-Care Testing (POCT) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Point-of-Care Testing (POCT) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Point-of-Care Testing (POCT) industry.
Chapter 3: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Point-of-Care Testing (POCT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Point-of-Care Testing (POCT) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Point-of-Care Testing (POCT) Sales Value (2019-2030)
1.2.2 Global Point-of-Care Testing (POCT) Sales Volume (2019-2030)
1.2.3 Global Point-of-Care Testing (POCT) Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 POINT-OF-CARE TESTING (POCT) MARKET DYNAMICS
2.1 Point-of-Care Testing (POCT) Industry Trends
2.2 Point-of-Care Testing (POCT) Industry Drivers
2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
2.4 Point-of-Care Testing (POCT) Industry Restraints
3 POINT-OF-CARE TESTING (POCT) MARKET BY COMPANY
3.1 Global Point-of-Care Testing (POCT) Company Revenue Ranking in 2023
3.2 Global Point-of-Care Testing (POCT) Revenue by Company (2019-2024)
3.3 Global Point-of-Care Testing (POCT) Sales Volume by Company (2019-2024)
3.4 Global Point-of-Care Testing (POCT) Average Price by Company (2019-2024)
3.5 Global Point-of-Care Testing (POCT) Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Point-of-Care Testing (POCT) Company Manufacturing Base & Headquarters
3.7 Global Point-of-Care Testing (POCT) Company, Product Type & Application
3.8 Global Point-of-Care Testing (POCT) Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE TESTING (POCT) MARKET BY TYPE
4.1 Point-of-Care Testing (POCT) Type Introduction
4.1.1 Blood Glucose Testing
4.1.2 Infectious Diseases Testing
4.1.3 Cardiac Markers Testing
4.1.4 Coagulation Testing
4.1.5 Pregnancy and Fertility Testing
4.1.6 Blood Gas/Electrolytes Testing
4.1.7 Urinalysis Testing
4.2 Global Point-of-Care Testing (POCT) Sales Volume by Type
4.2.1 Global Point-of-Care Testing (POCT) Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Point-of-Care Testing (POCT) Sales Volume by Type (2019-2030)
4.2.3 Global Point-of-Care Testing (POCT) Sales Volume Share by Type (2019-2030)
4.3 Global Point-of-Care Testing (POCT) Sales Value by Type
4.3.1 Global Point-of-Care Testing (POCT) Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Point-of-Care Testing (POCT) Sales Value by Type (2019-2030)
4.3.3 Global Point-of-Care Testing (POCT) Sales Value Share by Type (2019-2030)
5 POINT-OF-CARE TESTING (POCT) MARKET BY APPLICATION
5.1 Point-of-Care Testing (POCT) Application Introduction
5.1.1 Clinics
5.1.2 Hospitals
5.1.3 Laboratory
5.1.4 Others
5.2 Global Point-of-Care Testing (POCT) Sales Volume by Application
5.2.1 Global Point-of-Care Testing (POCT) Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Point-of-Care Testing (POCT) Sales Volume by Application (2019-2030)
5.2.3 Global Point-of-Care Testing (POCT) Sales Volume Share by Application (2019-2030)
5.3 Global Point-of-Care Testing (POCT) Sales Value by Application
5.3.1 Global Point-of-Care Testing (POCT) Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Point-of-Care Testing (POCT) Sales Value by Application (2019-2030)
5.3.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application (2019-2030)
6 POINT-OF-CARE TESTING (POCT) MARKET BY REGION
6.1 Global Point-of-Care Testing (POCT) Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Point-of-Care Testing (POCT) Sales by Region (2019-2030)
6.2.1 Global Point-of-Care Testing (POCT) Sales by Region: 2019-2024
6.2.2 Global Point-of-Care Testing (POCT) Sales by Region (2025-2030)
6.3 Global Point-of-Care Testing (POCT) Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Point-of-Care Testing (POCT) Sales Value by Region (2019-2030)
6.4.1 Global Point-of-Care Testing (POCT) Sales Value by Region: 2019-2024
6.4.2 Global Point-of-Care Testing (POCT) Sales Value by Region (2025-2030)
6.5 Global Point-of-Care Testing (POCT) Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.6.2 North America Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.7.2 Europe Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.8.2 Asia-Pacific Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.9.2 Latin America Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.10.2 Middle East & Africa Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
7 POINT-OF-CARE TESTING (POCT) MARKET BY COUNTRY
7.1 Global Point-of-Care Testing (POCT) Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Point-of-Care Testing (POCT) Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Point-of-Care Testing (POCT) Sales by Country (2019-2030)
7.3.1 Global Point-of-Care Testing (POCT) Sales by Country (2019-2024)
7.3.2 Global Point-of-Care Testing (POCT) Sales by Country (2025-2030)
7.4 Global Point-of-Care Testing (POCT) Sales Value by Country (2019-2030)
7.4.1 Global Point-of-Care Testing (POCT) Sales Value by Country (2019-2024)
7.4.2 Global Point-of-Care Testing (POCT) Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.5.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.6.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.7.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.8.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.9.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.10.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.11.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.12.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.13.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.14.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.15.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.16.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.17.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.18.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.19.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.20.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.21.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.22.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.23.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
8.1.5 Roche Recent Developments
8.2 Abbott
8.2.1 Abbott Comapny Information
8.2.2 Abbott Business Overview
8.2.3 Abbott Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
8.2.5 Abbott Recent Developments
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Comapny Information
8.3.2 Johnson & Johnson Business Overview
8.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
8.3.5 Johnson & Johnson Recent Developments
8.4 Siemens Healthcare
8.4.1 Siemens Healthcare Comapny Information
8.4.2 Siemens Healthcare Business Overview
8.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
8.4.5 Siemens Healthcare Recent Developments
8.5 Danaher
8.5.1 Danaher Comapny Information
8.5.2 Danaher Business Overview
8.5.3 Danaher Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
8.5.5 Danaher Recent Developments
8.6 Ascensia
8.6.1 Ascensia Comapny Information
8.6.2 Ascensia Business Overview
8.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
8.6.5 Ascensia Recent Developments
8.7 Bio-Rad Laboratories
8.7.1 Bio-Rad Laboratories Comapny Information
8.7.2 Bio-Rad Laboratories Business Overview
8.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
8.7.5 Bio-Rad Laboratories Recent Developments
8.8 BioMerieux
8.8.1 BioMerieux Comapny Information
8.8.2 BioMerieux Business Overview
8.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
8.8.5 BioMerieux Recent Developments
8.9 ARKRAY
8.9.1 ARKRAY Comapny Information
8.9.2 ARKRAY Business Overview
8.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
8.9.5 ARKRAY Recent Developments
8.10 Nova Biomedical
8.10.1 Nova Biomedical Comapny Information
8.10.2 Nova Biomedical Business Overview
8.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
8.10.5 Nova Biomedical Recent Developments
8.11 Trividia Health
8.11.1 Trividia Health Comapny Information
8.11.2 Trividia Health Business Overview
8.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
8.11.5 Trividia Health Recent Developments
8.12 Quidel
8.12.1 Quidel Comapny Information
8.12.2 Quidel Business Overview
8.12.3 Quidel Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
8.12.5 Quidel Recent Developments
8.13 Accriva
8.13.1 Accriva Comapny Information
8.13.2 Accriva Business Overview
8.13.3 Accriva Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
8.13.5 Accriva Recent Developments
8.14 OraSure Technologies
8.14.1 OraSure Technologies Comapny Information
8.14.2 OraSure Technologies Business Overview
8.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
8.14.5 OraSure Technologies Recent Developments
8.15 Helena Laboratories
8.15.1 Helena Laboratories Comapny Information
8.15.2 Helena Laboratories Business Overview
8.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
8.15.5 Helena Laboratories Recent Developments
8.16 A. Menarini Diagnostics
8.16.1 A. Menarini Diagnostics Comapny Information
8.16.2 A. Menarini Diagnostics Business Overview
8.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.16.5 A. Menarini Diagnostics Recent Developments
8.17 Abaxis (Zoetis)
8.17.1 Abaxis (Zoetis) Comapny Information
8.17.2 Abaxis (Zoetis) Business Overview
8.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
8.17.5 Abaxis (Zoetis) Recent Developments
8.18 Ortho Clinical Diagnostics
8.18.1 Ortho Clinical Diagnostics Comapny Information
8.18.2 Ortho Clinical Diagnostics Business Overview
8.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.18.5 Ortho Clinical Diagnostics Recent Developments
8.19 Phamatech
8.19.1 Phamatech Comapny Information
8.19.2 Phamatech Business Overview
8.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
8.19.5 Phamatech Recent Developments
8.20 Chembio Diagnostics
8.20.1 Chembio Diagnostics Comapny Information
8.20.2 Chembio Diagnostics Business Overview
8.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.20.5 Chembio Diagnostics Recent Developments
8.21 Trinity Biotech
8.21.1 Trinity Biotech Comapny Information
8.21.2 Trinity Biotech Business Overview
8.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
8.21.5 Trinity Biotech Recent Developments
8.22 ELITech Group
8.22.1 ELITech Group Comapny Information
8.22.2 ELITech Group Business Overview
8.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
8.22.5 ELITech Group Recent Developments
8.23 Response Biomedical
8.23.1 Response Biomedical Comapny Information
8.23.2 Response Biomedical Business Overview
8.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
8.23.5 Response Biomedical Recent Developments
8.24 Princeton BioMeditech
8.24.1 Princeton BioMeditech Comapny Information
8.24.2 Princeton BioMeditech Business Overview
8.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
8.24.5 Princeton BioMeditech Recent Developments
8.25 Alfa Wassermann
8.25.1 Alfa Wassermann Comapny Information
8.25.2 Alfa Wassermann Business Overview
8.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
8.25.5 Alfa Wassermann Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Point-of-Care Testing (POCT) Value Chain Analysis
9.1.1 Point-of-Care Testing (POCT) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Point-of-Care Testing (POCT) Sales Mode & Process
9.2 Point-of-Care Testing (POCT) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Point-of-Care Testing (POCT) Distributors
9.2.3 Point-of-Care Testing (POCT) Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Point-of-Care Testing (POCT) Sales Value (2019-2030)
1.2.2 Global Point-of-Care Testing (POCT) Sales Volume (2019-2030)
1.2.3 Global Point-of-Care Testing (POCT) Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 POINT-OF-CARE TESTING (POCT) MARKET DYNAMICS
2.1 Point-of-Care Testing (POCT) Industry Trends
2.2 Point-of-Care Testing (POCT) Industry Drivers
2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
2.4 Point-of-Care Testing (POCT) Industry Restraints
3 POINT-OF-CARE TESTING (POCT) MARKET BY COMPANY
3.1 Global Point-of-Care Testing (POCT) Company Revenue Ranking in 2023
3.2 Global Point-of-Care Testing (POCT) Revenue by Company (2019-2024)
3.3 Global Point-of-Care Testing (POCT) Sales Volume by Company (2019-2024)
3.4 Global Point-of-Care Testing (POCT) Average Price by Company (2019-2024)
3.5 Global Point-of-Care Testing (POCT) Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Point-of-Care Testing (POCT) Company Manufacturing Base & Headquarters
3.7 Global Point-of-Care Testing (POCT) Company, Product Type & Application
3.8 Global Point-of-Care Testing (POCT) Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE TESTING (POCT) MARKET BY TYPE
4.1 Point-of-Care Testing (POCT) Type Introduction
4.1.1 Blood Glucose Testing
4.1.2 Infectious Diseases Testing
4.1.3 Cardiac Markers Testing
4.1.4 Coagulation Testing
4.1.5 Pregnancy and Fertility Testing
4.1.6 Blood Gas/Electrolytes Testing
4.1.7 Urinalysis Testing
4.2 Global Point-of-Care Testing (POCT) Sales Volume by Type
4.2.1 Global Point-of-Care Testing (POCT) Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Point-of-Care Testing (POCT) Sales Volume by Type (2019-2030)
4.2.3 Global Point-of-Care Testing (POCT) Sales Volume Share by Type (2019-2030)
4.3 Global Point-of-Care Testing (POCT) Sales Value by Type
4.3.1 Global Point-of-Care Testing (POCT) Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Point-of-Care Testing (POCT) Sales Value by Type (2019-2030)
4.3.3 Global Point-of-Care Testing (POCT) Sales Value Share by Type (2019-2030)
5 POINT-OF-CARE TESTING (POCT) MARKET BY APPLICATION
5.1 Point-of-Care Testing (POCT) Application Introduction
5.1.1 Clinics
5.1.2 Hospitals
5.1.3 Laboratory
5.1.4 Others
5.2 Global Point-of-Care Testing (POCT) Sales Volume by Application
5.2.1 Global Point-of-Care Testing (POCT) Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Point-of-Care Testing (POCT) Sales Volume by Application (2019-2030)
5.2.3 Global Point-of-Care Testing (POCT) Sales Volume Share by Application (2019-2030)
5.3 Global Point-of-Care Testing (POCT) Sales Value by Application
5.3.1 Global Point-of-Care Testing (POCT) Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Point-of-Care Testing (POCT) Sales Value by Application (2019-2030)
5.3.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application (2019-2030)
6 POINT-OF-CARE TESTING (POCT) MARKET BY REGION
6.1 Global Point-of-Care Testing (POCT) Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Point-of-Care Testing (POCT) Sales by Region (2019-2030)
6.2.1 Global Point-of-Care Testing (POCT) Sales by Region: 2019-2024
6.2.2 Global Point-of-Care Testing (POCT) Sales by Region (2025-2030)
6.3 Global Point-of-Care Testing (POCT) Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Point-of-Care Testing (POCT) Sales Value by Region (2019-2030)
6.4.1 Global Point-of-Care Testing (POCT) Sales Value by Region: 2019-2024
6.4.2 Global Point-of-Care Testing (POCT) Sales Value by Region (2025-2030)
6.5 Global Point-of-Care Testing (POCT) Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.6.2 North America Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.7.2 Europe Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.8.2 Asia-Pacific Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.9.2 Latin America Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Point-of-Care Testing (POCT) Sales Value (2019-2030)
6.10.2 Middle East & Africa Point-of-Care Testing (POCT) Sales Value Share by Country, 2023 VS 2030
7 POINT-OF-CARE TESTING (POCT) MARKET BY COUNTRY
7.1 Global Point-of-Care Testing (POCT) Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Point-of-Care Testing (POCT) Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Point-of-Care Testing (POCT) Sales by Country (2019-2030)
7.3.1 Global Point-of-Care Testing (POCT) Sales by Country (2019-2024)
7.3.2 Global Point-of-Care Testing (POCT) Sales by Country (2025-2030)
7.4 Global Point-of-Care Testing (POCT) Sales Value by Country (2019-2030)
7.4.1 Global Point-of-Care Testing (POCT) Sales Value by Country (2019-2024)
7.4.2 Global Point-of-Care Testing (POCT) Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.5.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.6.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.7.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.8.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.9.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.10.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.11.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.12.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.13.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.14.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.15.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.16.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.17.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.18.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.19.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.20.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.21.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.22.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Point-of-Care Testing (POCT) Sales Value Growth Rate (2019-2030)
7.23.2 Global Point-of-Care Testing (POCT) Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Point-of-Care Testing (POCT) Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Roche
8.1.1 Roche Comapny Information
8.1.2 Roche Business Overview
8.1.3 Roche Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
8.1.5 Roche Recent Developments
8.2 Abbott
8.2.1 Abbott Comapny Information
8.2.2 Abbott Business Overview
8.2.3 Abbott Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
8.2.5 Abbott Recent Developments
8.3 Johnson & Johnson
8.3.1 Johnson & Johnson Comapny Information
8.3.2 Johnson & Johnson Business Overview
8.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
8.3.5 Johnson & Johnson Recent Developments
8.4 Siemens Healthcare
8.4.1 Siemens Healthcare Comapny Information
8.4.2 Siemens Healthcare Business Overview
8.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
8.4.5 Siemens Healthcare Recent Developments
8.5 Danaher
8.5.1 Danaher Comapny Information
8.5.2 Danaher Business Overview
8.5.3 Danaher Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
8.5.5 Danaher Recent Developments
8.6 Ascensia
8.6.1 Ascensia Comapny Information
8.6.2 Ascensia Business Overview
8.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
8.6.5 Ascensia Recent Developments
8.7 Bio-Rad Laboratories
8.7.1 Bio-Rad Laboratories Comapny Information
8.7.2 Bio-Rad Laboratories Business Overview
8.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
8.7.5 Bio-Rad Laboratories Recent Developments
8.8 BioMerieux
8.8.1 BioMerieux Comapny Information
8.8.2 BioMerieux Business Overview
8.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
8.8.5 BioMerieux Recent Developments
8.9 ARKRAY
8.9.1 ARKRAY Comapny Information
8.9.2 ARKRAY Business Overview
8.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
8.9.5 ARKRAY Recent Developments
8.10 Nova Biomedical
8.10.1 Nova Biomedical Comapny Information
8.10.2 Nova Biomedical Business Overview
8.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
8.10.5 Nova Biomedical Recent Developments
8.11 Trividia Health
8.11.1 Trividia Health Comapny Information
8.11.2 Trividia Health Business Overview
8.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
8.11.5 Trividia Health Recent Developments
8.12 Quidel
8.12.1 Quidel Comapny Information
8.12.2 Quidel Business Overview
8.12.3 Quidel Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
8.12.5 Quidel Recent Developments
8.13 Accriva
8.13.1 Accriva Comapny Information
8.13.2 Accriva Business Overview
8.13.3 Accriva Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
8.13.5 Accriva Recent Developments
8.14 OraSure Technologies
8.14.1 OraSure Technologies Comapny Information
8.14.2 OraSure Technologies Business Overview
8.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
8.14.5 OraSure Technologies Recent Developments
8.15 Helena Laboratories
8.15.1 Helena Laboratories Comapny Information
8.15.2 Helena Laboratories Business Overview
8.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
8.15.5 Helena Laboratories Recent Developments
8.16 A. Menarini Diagnostics
8.16.1 A. Menarini Diagnostics Comapny Information
8.16.2 A. Menarini Diagnostics Business Overview
8.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.16.5 A. Menarini Diagnostics Recent Developments
8.17 Abaxis (Zoetis)
8.17.1 Abaxis (Zoetis) Comapny Information
8.17.2 Abaxis (Zoetis) Business Overview
8.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
8.17.5 Abaxis (Zoetis) Recent Developments
8.18 Ortho Clinical Diagnostics
8.18.1 Ortho Clinical Diagnostics Comapny Information
8.18.2 Ortho Clinical Diagnostics Business Overview
8.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.18.5 Ortho Clinical Diagnostics Recent Developments
8.19 Phamatech
8.19.1 Phamatech Comapny Information
8.19.2 Phamatech Business Overview
8.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
8.19.5 Phamatech Recent Developments
8.20 Chembio Diagnostics
8.20.1 Chembio Diagnostics Comapny Information
8.20.2 Chembio Diagnostics Business Overview
8.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
8.20.5 Chembio Diagnostics Recent Developments
8.21 Trinity Biotech
8.21.1 Trinity Biotech Comapny Information
8.21.2 Trinity Biotech Business Overview
8.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
8.21.5 Trinity Biotech Recent Developments
8.22 ELITech Group
8.22.1 ELITech Group Comapny Information
8.22.2 ELITech Group Business Overview
8.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
8.22.5 ELITech Group Recent Developments
8.23 Response Biomedical
8.23.1 Response Biomedical Comapny Information
8.23.2 Response Biomedical Business Overview
8.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
8.23.5 Response Biomedical Recent Developments
8.24 Princeton BioMeditech
8.24.1 Princeton BioMeditech Comapny Information
8.24.2 Princeton BioMeditech Business Overview
8.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
8.24.5 Princeton BioMeditech Recent Developments
8.25 Alfa Wassermann
8.25.1 Alfa Wassermann Comapny Information
8.25.2 Alfa Wassermann Business Overview
8.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Value and Gross Margin (2019-2024)
8.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
8.25.5 Alfa Wassermann Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Point-of-Care Testing (POCT) Value Chain Analysis
9.1.1 Point-of-Care Testing (POCT) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Point-of-Care Testing (POCT) Sales Mode & Process
9.2 Point-of-Care Testing (POCT) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Point-of-Care Testing (POCT) Distributors
9.2.3 Point-of-Care Testing (POCT) Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
